Articles

Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma

Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Dept. of Pediatrics - Research, The University of Texas M. D. Anderson Cancer Center, Houston, USA;
Lab. of Protein Design and Immunoengineering, Ecole Polytechnique Federale de Lausanne, Switzerland;
Department of Biosciences, U Science Tech. Universitat de Vic-Universitat Central de Catalunya,Spain;
Department of Immunology and Immunotherapy, Clinic Universitary of Navarra, Spain;
Department of Immunology and Immunotherapy, Clinic Universitary of Navarra, Spain;
Josep Carreras Leukemia Research Institute/ Cell Therapy Program of the School of Medicine,Barcelona;
Department of Immunotherapy, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Hospital Clinic, IDIBAPS,Josep Carreras Leukaemia Research Institute, University of Barcelona, Spain;
Hospital Clinic, IDIBAPS, Josep Carreras Leukaemia Research Institute, Barcelona, Spain
Haematologica Early view Jan 9, 2020 https://doi.org/10.3324/haematol.2019.228577